Premium Financials Agenda

Faça Login ou Cadastre-se para ter acesso completo.

Supercharge your analysis with exclusive data on more than 6000 companies.

All your companies centralized on a single place.

A powerful Screener with all companies and indicators available on the site.

All the companies you've bookmarked to learn more.

Compare up to 5 companies, using more than 900 exclusive indicators between Stocks, REITs, Ações and FIIs.

Review and analyze updated financials of more than 6.000 Stocks, REITs, FIIs and Ações.

See the most complete corporate Events Calendar in the world.

Don't miss anything regarding the companies that matter most. Join our discussions.

All material facts published in the last 90 days.

Get ahead with the best companies ranked by the community.

CHRS

CHRS

Price • Coherus BioSciences

CHRS

Coherus BioSciences Inc is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline which includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust antitumor immunologic response and enhance outcomes for patients with cancer.

Historical stock price chart and annual return over the past years

-95%

5 years

% Total

CHRS

-45%

5 years

Annual Return

CHRS